Name: Computational Biology Market Size, Share, Industry, Forecast and Outlook (2023-2030)
Brand: DataM Intelligence
SKU: 1701
Price: 4350 USD
Availability: InStock

Computational Biology Market Size, Share, Trends & Forecast 2023-2030

Computational Biology Market Size, Share, Industry, Forecast and Outlook (2023-2030)

<h2>Global Computational Biology Market is segmented By Application (Cellular &amp; Biological Simulation, Drug Discovery &amp; Disease Modelling, Preclinical Drug Development, Clinical Trials, Human Body Simulation Software), By Tool (Databases, Infrastructure, Analysis Software and Services), By Service (In-House, Contract), By End User (Academics, Industry, Commercial), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) &ndash; Share, Size, Outlook, and Opportunity Analysis, 2023-2030</h2>

<h2>&nbsp;</h2>

<h2>Computational Biology Market Overview</h2>

<blockquote>
The Global &quot;Computational Biology Market&quot;&nbsp;is expected to grow at a <a href="https://www.datamintelligence.com/download-sample/computational-biology-market">CAGR of 21.5%</a> during the forecasting period (2023-2030).
</blockquote>

<h2>Why Purchase the Report?</h2>

<ul>
	<li>Visualize the composition of the Computational Biology Market products across each product type and application highlighting the critical commercial assets and players.</li>
	<li>Identify commercial opportunities in the Computational Biology Market by analyzing trends and co-development deals.</li>
	<li>Comprehensive details on factors driving the market growth.</li>
	<li>Excel data sheet with thousands of data points of Computational Biology Market segmentation.</li>
	<li>PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.</li>
</ul>

<h2>Target Audience</h2>

<ul>
	<li>Industry Investors/Investment Bankers</li>
	<li>Suppliers/Buyers</li>
	<li><a href="https://www.datamintelligence.com/enquiry/computational-biology-market">Education &amp; Research Institutes</a></li>
	<li>Manufacturers</li>
	<li>Research Professionals</li>
	<li>Emerging Companies</li>
	<li>Distributors</li>
</ul>

<h3 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">Trending Topics</h3>

<a href="https://www.datamintelligence.com/research-report/synthetic-biology-market">Synthetic Biology Market</a>

<a href="https://www.datamintelligence.com/research-report/clinical-microbiology-market">Clinical Microbiology Market</a>

<h2>&nbsp;</h2>

<ol>
	<li>
	<h3>Methodology and Scope</h3>

	<ol>
		<li>
		Research Methodology
		</li>
		<li>
		Research Objective and Scope of the Report
		</li>
	</ol>
	</li>
	<li>
	<h3>Market Definition and Overview</h3>
	</li>
	<li>
	<h3>Executive Summary</h3>

	<ol>
		<li>
		Market Snippet by Application
		</li>
		<li>
		Market Snippet by Tool
		</li>
		<li>
		Market Snippet by Service
		</li>
		<li>
		Market Snippet by End User
		</li>
		<li>
		DataM CLO Scenario
		</li>
	</ol>
	</li>
	<li>
	<h3>Market Dynamics</h3>

	<ol>
		<li>
		Market Impacting Factors

		<ol>
			<li>
			Drivers

			<ol>
				<li>
				&nbsp;Increase in research activities for drug discovery processes
				</li>
				<li>
				Innovations in biological computation tools
				</li>
			</ol>
			</li>
			<li>
			Restraints

			<ol>
				<li>
				Lack of skilled resources to operate computational tools
				</li>
			</ol>
			</li>
			<li>
			Impact Analysis
			</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3>Industry Analysis</h3>

	<ol>
		<li>
		Porter&#39;s Five Forces Analysis
		</li>
		<li>
		Supply Chain Analysis
		</li>
		<li>
		Regulatory Analysis
		</li>
		<li>
		Pricing Analysis
		</li>
		<li>
		Technology Advances
		</li>
		<li>
		Key Companies to Watch
		</li>
		<li>
		Epidemiology
		</li>
	</ol>
	</li>
	<li>
	<h3>By Application</h3>

	<ol>
		<li>
		Introduction
		</li>
		<li>
		Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
		</li>
		<li>
		Market Attractiveness Index, By Application
		</li>
		<li>
		Cellular &amp; Biological Simulation

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%)
			</li>
		</ol>
		</li>
		<li>
		Drug Discovery &amp; Disease Modelling
		</li>
		<li>
		Preclinical Drug Development
		</li>
		<li>
		Clinical Trials
		</li>
		<li>
		Human Body Simulation Software
		</li>
	</ol>
	</li>
	<li>
	<h3>By Tool</h3>

	<ol>
		<li>
		Introduction
		</li>
		<li>
		Market Size Analysis, and Y-o-Y Growth Analysis (%), By Tool
		</li>
		<li>
		Market Attractiveness Index, By Tool
		</li>
		<li>
		Databases

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%)
			</li>
		</ol>
		</li>
		<li>
		Infrastructure
		</li>
		<li>
		Analysis Software and Services
		</li>
	</ol>
	</li>
	<li>
	<h3>By Service</h3>

	<ol>
		<li>
		Introduction
		</li>
		<li>
		Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service
		</li>
		<li>
		Market Attractiveness Index, By Service
		</li>
		<li>
		In-House

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%)
			</li>
		</ol>
		</li>
		<li>
		Contract
		</li>
	</ol>
	</li>
	<li>
	<h3>By End User</h3>

	<ol>
		<li>
		Introduction
		</li>
		<li>
		Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
		</li>
		<li>
		Market Attractiveness Index, By End User
		</li>
		<li>
		Academics

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%)
			</li>
		</ol>
		</li>
		<li>
		Industry
		</li>
		<li>
		Commercial
		</li>
	</ol>
	</li>
	<li>
	<h3>Global Computational Biology MarketBy Region</h3>

	<ol>
		<li>
		Introduction
		</li>
		<li>
		Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
		</li>
		<li>
		Market Attractiveness Index, By Region
		</li>
		<li>
		North America

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Tool
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

			<ol>
				<li>
				U.S.
				</li>
				<li>
				Canada
				</li>
				<li>
				Mexico
				</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>
		Europe

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Tool
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

			<ol>
				<li>
				Germany
				</li>
				<li>
				U.K.
				</li>
				<li>
				France
				</li>
				<li>
				Italy
				</li>
				<li>
				Spain
				</li>
				<li>
				Rest of Europe
				</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>
		South America

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Tool
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

			<ol>
				<li>
				Brazil
				</li>
				<li>
				Argentina
				</li>
				<li>
				Rest of South America
				</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>
		Asia-Pacific

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Tool
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

			<ol>
				<li>
				China
				</li>
				<li>
				India
				</li>
				<li>
				Japan
				</li>
				<li>
				Australia
				</li>
				<li>
				Rest of Asia Pacific
				</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>
		Middle East and Africa

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Tool
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
			</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3>Global Market Competitive Landscape</h3>

	<ol>
		<li>
		Competitive Scenario
		</li>
		<li>
		Competitor Computational Biology Strategy Analysis
		</li>
		<li>
		Comparative Drug Portfolio Analysis
		</li>
		<li>
		Market Positioning/Share Analysis
		</li>
		<li>
		Mergers and Acquisitions Analysis
		</li>
	</ol>
	</li>
	<li>
	<h3>Company Profiles</h3>

	<ol>
		<li>
		Chemical Computing group.

		<ol>
			<li>
			Company Overview
			</li>
			<li>
			Drug Portfolio and Description
			</li>
			<li>
			Key Highlights
			</li>
			<li>
			Financial Overview
			</li>
		</ol>
		</li>
		<li>
		Simulation Plus Inc
		</li>
		<li>
		Genedata AG
		</li>
		<li>
		Insilico Biotechnology AG
		</li>
		<li>
		Rhenovia Pharma SAS.
		</li>
		<li>
		Compugen Ltd.
		</li>
		<li>
		Certara.
		</li>
		<li>
		Accelrys
		</li>
		<li>
		Nimbus Discovery LLC.
		</li>
		<li>
		Strand life sciences Pvt ltd
		</li>
	</ol>
	</li>
	<li>
	<h3>Premium Insights</h3>
	</li>
	<li>
	<h3>DataM Intelligence</h3>

	<ol>
		<li>
		Appendix
		</li>
		<li>
		About Us and Services
		</li>
		<li>
		Contact Us
		</li>
	</ol>
	</li>
</ol>

LIST OF TABLES

TABLE 01.&nbsp;&nbsp; &nbsp;GLOBAL COMPUTATIONAL BIOLOGY MARKET VALUE, 2021, 2025 &amp; 2029, BY APPLICATION, ($MILLION)

TABLE 02.&nbsp;&nbsp; &nbsp;GLOBAL COMPUTATIONAL BIOLOGY MARKET VALUE, 2021, 2025 &amp; 2029, BY TOOL, ($MILLION)

TABLE 03.&nbsp;&nbsp; &nbsp;GLOBAL COMPUTATIONAL BIOLOGY MARKET VALUE, 2021, 2025 &amp; 2029, BY SERVICE, ($MILLION)

TABLE 04.&nbsp;&nbsp; &nbsp;GLOBAL COMPUTATIONAL BIOLOGY MARKET VALUE, 2021, 2025 &amp; 2029, BY END-USER, ($MILLION)

TABLE 05.&nbsp;&nbsp; &nbsp;GLOBAL COMPUTATIONAL BIOLOGY MARKET VALUE 2021, 2025 &amp; 2029, BY REGION, ($MILLION)

TABLE 06.&nbsp;&nbsp; &nbsp;GLOBAL COMPUTATIONAL BIOLOGY MARKET SHARE 2021, 2025 &amp; 2029 (%), BY APPLICATION ($MILLION)

TABLE 07.&nbsp;&nbsp; &nbsp;GLOBAL COMPUTATIONAL BIOLOGY MARKET VALUE, BY APPLICATION, 2021&ndash;2029 ($MILLION)

TABLE 08.&nbsp;&nbsp; &nbsp;GLOBAL COMPUTATIONAL BIOLOGY MARKET SHARE 2021, 2025 &amp; 2029 (%), BY TOOL ($MILLION)

TABLE 09.&nbsp;&nbsp; &nbsp;GLOBAL COMPUTATIONAL BIOLOGY MARKET VALUE, BY TOOL, 2021&ndash;2029 ($MILLION)

TABLE 10.&nbsp;&nbsp; &nbsp;GLOBAL COMPUTATIONAL BIOLOGY MARKET SHARE 2021, 2025 &amp; 2029 (%), BY SERVICE ($MILLION)

TABLE 11.&nbsp;&nbsp; &nbsp;GLOBAL COMPUTATIONAL BIOLOGY MARKET VALUE, BY SERVICE, 2021&ndash;2029 ($MILLION)

TABLE 12.&nbsp;&nbsp; &nbsp;GLOBAL COMPUTATIONAL BIOLOGY MARKET SHARE 2021, 2025 &amp; 2029 (%), BY END-USER ($MILLION)

TABLE 13.&nbsp;&nbsp; &nbsp;GLOBAL COMPUTATIONAL BIOLOGY MARKET VALUE, BY END-USER, 2021&ndash;2029 ($MILLION)

TABLE 14.&nbsp;&nbsp; &nbsp;GLOBAL COMPUTATIONAL BIOLOGY MARKET SHARE 2021, 2025 &amp; 2029 (%), BY REGION ($MILLION)

TABLE 15.&nbsp;&nbsp; &nbsp;GLOBAL COMPUTATIONAL BIOLOGY MARKET VALUE, BY REGION, 2021&ndash;2029 ($MILLION)

TABLE 16.&nbsp;&nbsp; &nbsp;NORTH AMERICA COMPUTATIONAL BIOLOGY MARKET VALUE, BY APPLICATION, 2021&ndash;2029 ($MILLION)

TABLE 17.&nbsp;&nbsp; &nbsp;NORTH AMERICA COMPUTATIONAL BIOLOGY MARKET VALUE, BY TOOL, 2021&ndash;2029 ($MILLION)

TABLE 18.&nbsp;&nbsp;NORTH AMERICA COMPUTATIONAL BIOLOGY MARKET VALUE, BY SERVICE, 2021&ndash;2029 ($MILLION) &nbsp;

TABLE 19.&nbsp;&nbsp;NORTH AMERICA COMPUTATIONAL BIOLOGY MARKET VALUE, BY END-USER, 2021&ndash;2029 ($MILLION) &nbsp;

TABLE 20.&nbsp;&nbsp; &nbsp;NORTH AMERICA COMPUTATIONAL BIOLOGY MARKET VALUE, BY COUNTRY, 2021&ndash;2029 ($MILLION)

TABLE 21.&nbsp;&nbsp; &nbsp;SOUTH AMERICA COMPUTATIONAL BIOLOGY MARKET VALUE, BY APPLICATION, 2021&ndash;2029 ($MILLION)

TABLE 22.&nbsp;&nbsp; &nbsp;SOUTH AMERICA COMPUTATIONAL BIOLOGY MARKET VALUE, BY TOOL, 2021&ndash;2029 ($MILLION)

TABLE 23.&nbsp;&nbsp; SOUTH AMERICA COMPUTATIONAL BIOLOGY MARKET VALUE, BY SERVICE, 2021&ndash;2029 ($MILLION)&nbsp;

TABLE 24.&nbsp;&nbsp; SOUTH AMERICA COMPUTATIONAL BIOLOGY MARKET VALUE, BY END-USER, 2021&ndash;2029 ($MILLION)&nbsp;

TABLE 25.&nbsp;&nbsp; &nbsp;SOUTH AMERICA COMPUTATIONAL BIOLOGY MARKET VALUE, BY COUNTRY, 2021&ndash;2029 ($MILLION)

TABLE 26.&nbsp;&nbsp; &nbsp;EUROPE COMPUTATIONAL BIOLOGY MARKET VALUE, BY APPLICATION, 2021&ndash;2029 ($MILLION)

TABLE 27.&nbsp;&nbsp; &nbsp;EUROPE COMPUTATIONAL BIOLOGY MARKET VALUE, BY TOOL, 2021&ndash;2029 ($MILLION)

TABLE 28.&nbsp;&nbsp; &nbsp;EUROPE COMPUTATIONAL BIOLOGY MARKET VALUE, BY SERVICE, 2021&ndash;2029 ($MILLION)

TABLE 29.&nbsp;&nbsp; &nbsp;EUROPE COMPUTATIONAL BIOLOGY MARKET VALUE, BY END-USER, 2021&ndash;2029 ($MILLION)

TABLE 30.&nbsp;&nbsp; &nbsp;EUROPE COMPUTATIONAL BIOLOGY MARKET VALUE, BY COUNTRY, 2021&ndash;2029 ($MILLION)

TABLE 31.&nbsp;&nbsp; &nbsp;ASIA PACIFIC COMPUTATIONAL BIOLOGY MARKET VALUE, BY APPLICATION, 2021&ndash;2029 ($MILLION)

TABLE 32.&nbsp;&nbsp; &nbsp;ASIA PACIFIC COMPUTATIONAL BIOLOGY MARKET VALUE, BY TOOL, 2021&ndash;2029 ($MILLION)

TABLE 33.&nbsp;&nbsp;ASIA PACIFIC COMPUTATIONAL BIOLOGY MARKET VALUE, BY SERVICE, 2021&ndash;2029 ($MILLION)

TABLE 34.&nbsp;&nbsp;ASIA PACIFIC COMPUTATIONAL BIOLOGY MARKET VALUE, BY END-USER, 2021&ndash;2029 ($MILLION)

TABLE 35.&nbsp;&nbsp; &nbsp;ASIA PACIFIC COMPUTATIONAL BIOLOGY MARKET VALUE, BY COUNTRY, 2021&ndash;2029 ($MILLION)

TABLE 36.&nbsp;&nbsp; &nbsp;MIDDLE EAST &amp; AFRICA COMPUTATIONAL BIOLOGY MARKET VALUE, BY APPLICATION, 2021&ndash;2029 ($MILLION)

TABLE 37.&nbsp;&nbsp; &nbsp;MIDDLE EAST &amp; AFRICA COMPUTATIONAL BIOLOGY MARKET VALUE, BY TOOL, 2021&ndash;2029 ($MILLION)

TABLE 38.&nbsp;&nbsp; &nbsp;MIDDLE EAST &amp; AFRICA COMPUTATIONAL BIOLOGY MARKET VALUE, BY SERVICE, 2021&ndash;2029 ($MILLION)

TABLE 39.&nbsp;&nbsp; &nbsp;MIDDLE EAST &amp; AFRICA COMPUTATIONAL BIOLOGY MARKET VALUE, BY END-USER, 2021&ndash;2029 ($MILLION)

TABLE 40.&nbsp;&nbsp; &nbsp;CHEMICAL COMPUTING GROUP.: OVERVIEW

TABLE 41.&nbsp;&nbsp; &nbsp;CHEMICAL COMPUTING GROUP.: PRODUCT PORTFOLIO

TABLE 42.&nbsp;&nbsp; &nbsp;CHEMICAL COMPUTING GROUP.: KEY DEVELOPMENTS

TABLE 43.&nbsp;&nbsp; &nbsp;SIMULATION PLUS INC: OVERVIEW

TABLE 44.&nbsp;&nbsp; &nbsp;SIMULATION PLUS INC: PRODUCT PORTFOLIO

TABLE 45.&nbsp;&nbsp; &nbsp;SIMULATION PLUS INC: KEY DEVELOPMENTS

TABLE 46.&nbsp;&nbsp; &nbsp;GENEDATA AG: OVERVIEW

TABLE 47.&nbsp;&nbsp; &nbsp;GENEDATA AG: PRODUCT PORTFOLIO

TABLE 48.&nbsp;&nbsp; &nbsp;GENEDATA AG: KEY DEVELOPMENTS

TABLE 49.&nbsp;&nbsp; &nbsp;INSILICO BIOTECHNOLOGY AG: OVERVIEW

TABLE 50.&nbsp;&nbsp; &nbsp;INSILICO BIOTECHNOLOGY AG: PRODUCT PORTFOLIO

TABLE 51.&nbsp;&nbsp; &nbsp;INSILICO BIOTECHNOLOGY AG: KEY DEVELOPMENTS

TABLE 52.&nbsp;&nbsp; &nbsp;RHENOVIA PHARMA SAS.: OVERVIEW

TABLE 53.&nbsp;&nbsp; &nbsp;RHENOVIA PHARMA SAS.: PRODUCT PORTFOLIO

TABLE 54.&nbsp;&nbsp; &nbsp;RHENOVIA PHARMA SAS.: KEY DEVELOPMENTS

TABLE 55.&nbsp;&nbsp; &nbsp;COMPUGEN LTD.: OVERVIEW

TABLE 56.&nbsp;&nbsp; &nbsp;COMPUGEN LTD.: PRODUCT PORTFOLIO

TABLE 57.&nbsp;&nbsp; &nbsp;COMPUGEN LTD.: KEY DEVELOPMENTS

TABLE 58.&nbsp;&nbsp; &nbsp;CERTARA.: OVERVIEW

TABLE 59.&nbsp;&nbsp; &nbsp;CERTARA.: PRODUCT PORTFOLIO

TABLE 60.&nbsp;&nbsp; &nbsp;CERTARA.: KEY DEVELOPMENTS

TABLE 61.&nbsp;&nbsp; &nbsp;ACCELRYS: OVERVIEW

TABLE 62.&nbsp;&nbsp; &nbsp;ACCELRYS: PRODUCT PORTFOLIO

TABLE 63.&nbsp;&nbsp; &nbsp;ACCELRYS: KEY DEVELOPMENTS

TABLE 64.&nbsp;&nbsp; &nbsp;&nbsp;NIMBUS DISCOVERY LLC.: OVERVIEW

TABLE 65.&nbsp;&nbsp; &nbsp;&nbsp;NIMBUS DISCOVERY LLC.: PRODUCT PORTFOLIO

TABLE 66.&nbsp;&nbsp; &nbsp;&nbsp;NIMBUS DISCOVERY LLC.: KEY DEVELOPMENTS

TABLE 67.&nbsp;&nbsp; &nbsp;STRAND LIFE SCIENCES PVT LTD: OVERVIEW

TABLE 68.&nbsp;&nbsp; &nbsp;STRAND LIFE SCIENCES PVT LTD: PRODUCT PORTFOLIO

TABLE 69.&nbsp;&nbsp; &nbsp;STRAND LIFE SCIENCES PVT LTD: KEY DEVELOPMENTS

<h3>LIST OF FIGURES</h3>

FIGURE 01.&nbsp;&nbsp; &nbsp;GLOBAL COMPUTATIONAL BIOLOGY MARKET SHARE, 2021 &amp; 2029 (%), BY APPLICATION&nbsp;&nbsp; &nbsp;

FIGURE 02.&nbsp;&nbsp; &nbsp;GLOBAL COMPUTATIONAL BIOLOGY MARKET SHARE, 2021 &amp; 2029 (%), BY TOOL

FIGURE 03.&nbsp;&nbsp; &nbsp;GLOBAL COMPUTATIONAL BIOLOGY MARKET SHARE, 2021 &amp; 2029 (%), BY SERVICE

FIGURE 04.&nbsp;&nbsp; &nbsp;GLOBAL COMPUTATIONAL BIOLOGY MARKET SHARE, 2021 &amp; 2029 (%), BY END-USER

FIGURE 05.&nbsp;&nbsp; &nbsp;GLOBAL COMPUTATIONAL BIOLOGY MARKET SHARE, 2021 &amp; 2029 (%), BY REGION

FIGURE 06.&nbsp;&nbsp; &nbsp;GLOBAL COMPUTATIONAL BIOLOGY MARKET VALUE, 2021 - 2029 AND YEAR ON YEAR GROWTH

FIGURE 07.&nbsp;&nbsp; &nbsp;GLOBAL COMPUTATIONAL BIOLOGY MARKETYEAR ON YEAR GROWTH 2021 TO 2029 (%), BY APPLICATION

FIGURE 08. GLOBAL COMPUTATIONAL BIOLOGY MARKET VALUE, BY&nbsp;CELLULAR &amp; BIOLOGICAL SIMULATION, 2021&ndash;2029 ($MILLION)

FIGURE 09. GLOBAL COMPUTATIONAL BIOLOGY MARKET VALUE, BY&nbsp;DRUG DISCOVERY &amp; DISEASE MODELLING, 2021&ndash;2029 ($MILLION)

FIGURE 10. GLOBAL COMPUTATIONAL BIOLOGY MARKET VALUE, BY&nbsp;PRECLINICAL DRUG DEVELOPMENT, 2021&ndash;2029 ($MILLION)

FIGURE 11. GLOBAL COMPUTATIONAL BIOLOGY MARKET VALUE, BY&nbsp;CLINICAL TRIALS, 2021&ndash;2029 ($MILLION)

FIGURE 12. GLOBAL COMPUTATIONAL BIOLOGY MARKET VALUE, BY&nbsp;HUMAN BODY SIMULATION SOFTWARE, 2021&ndash;2029 ($MILLION)

FIGURE 13.&nbsp;&nbsp; &nbsp;GLOBAL COMPUTATIONAL BIOLOGY MARKET YEAR ON YEAR GROWTH 2021 TO 2029 (%), BY TOOL

FIGURE 14. GLOBAL COMPUTATIONAL BIOLOGY MARKET VALUE, BY&nbsp;DATABASES, 2021&ndash;2029 ($MILLION)

FIGURE 15. GLOBAL COMPUTATIONAL BIOLOGY MARKET VALUE, BY&nbsp;INFRASTRUCTURE, 2021&ndash;2029 ($MILLION)

FIGURE 16. GLOBAL COMPUTATIONAL BIOLOGY MARKET VALUE, BY&nbsp;ANALYSIS SOFTWARE AND SERVICES, 2021&ndash;2029 ($MILLION)

FIGURE 17.&nbsp;&nbsp; &nbsp;GLOBAL COMPUTATIONAL BIOLOGY MARKET YEAR ON YEAR GROWTH 2021 TO 2029 (%), BY SERVICE

FIGURE 18. GLOBAL COMPUTATIONAL BIOLOGY MARKET VALUE, BY&nbsp;IN-HOUSE, 2021&ndash;2029 ($MILLION)

FIGURE 19. GLOBAL COMPUTATIONAL BIOLOGY MARKET VALUE, BY&nbsp;CONTRACT, 2021&ndash;2029 ($MILLION)

FIGURE 20.&nbsp;&nbsp; &nbsp;GLOBAL COMPUTATIONAL BIOLOGY MARKET YEAR ON YEAR GROWTH 2021 TO 2029 (%), BY END-USER

FIGURE 21. GLOBAL COMPUTATIONAL BIOLOGY MARKET VALUE, BY&nbsp;ACADEMICS, 2021&ndash;2029 ($MILLION)

FIGURE 22. GLOBAL COMPUTATIONAL BIOLOGY MARKET VALUE, BY&nbsp;INDUSTRY,&nbsp;2021&ndash;2029 ($MILLION)

FIGURE 23. GLOBAL COMPUTATIONAL BIOLOGY MARKET VALUE, BY COMMERCIAL, 2021&ndash;2029 ($MILLION)

FIGURE 24.&nbsp;&nbsp; &nbsp;GLOBAL COMPUTATIONAL BIOLOGY MARKET YEAR ON YEAR GROWTH 2021 TO 2029 (%), BY REGION

FIGURE 25. NORTH AMERICA COMPUTATIONAL BIOLOGY MARKET VALUE, 2021&ndash;2029 ($MILLION)

FIGURE 26. NORTH AMERICA COMPUTATIONAL BIOLOGY MARKET SHARE (%), BY APPLICATION, 2021&ndash;2029 ($MILLION)

FIGURE 27. NORTH AMERICA COMPUTATIONAL BIOLOGY MARKET SHARE (%), BY TOOL, 2021&ndash;2029 ($MILLION)

FIGURE 28. NORTH AMERICA COMPUTATIONAL BIOLOGY MARKET SHARE (%), BY SERVICE, 2021&ndash;2029 ($MILLION)

FIGURE 29. NORTH AMERICA COMPUTATIONAL BIOLOGY MARKET SHARE (%), BY END-USER, 2021&ndash;2029 ($MILLION)

FIGURE 30. NORTH AMERICA COMPUTATIONAL BIOLOGY MARKET SHARE (%), BY COUNTRIES, 2021&ndash;2029 ($MILLION)

FIGURE 31. SOUTH AMERICA COMPUTATIONAL BIOLOGY MARKET VALUE, 2021&ndash;2029 ($MILLION)

FIGURE 32. SOUTH AMERICA COMPUTATIONAL BIOLOGY MARKET SHARE (%), BY APPLICATION, 2021-2029($MILLION)

FIGURE 33. SOUTH AMERICA COMPUTATIONAL BIOLOGY MARKET SHARE (%), BY TOOL, 2021-2029($MILLION)

FIGURE 34. SOUTH AMERICA COMPUTATIONAL BIOLOGY MARKET SHARE (%), BY SERVICE, 2021-2029($MILLION)

FIGURE 35. SOUTH AMERICA COMPUTATIONAL BIOLOGY MARKET SHARE (%), BY END-USER, 2021-2029($MILLION)

FIGURE 36. SOUTH AMERICA COMPUTATIONAL BIOLOGY MARKET SHARE (%), BY COUNTRIES, 2021&ndash;2029 ($MILLION)

FIGURE 37. EUROPE COMPUTATIONAL BIOLOGY MARKET VALUE, 2021&ndash;2029 ($MILLION)

FIGURE 38. EUROPE COMPUTATIONAL BIOLOGY MARKET SHARE (%), BY APPLICATION, 2021&ndash;2029 ($MILLION)

FIGURE 39. EUROPE COMPUTATIONAL BIOLOGY MARKET SHARE (%), BY TOOL, 2021&ndash;2029 ($MILLION)

FIGURE 40. EUROPE COMPUTATIONAL BIOLOGY MARKET SHARE (%), BY SERVICE, 2021&ndash;2029 ($MILLION)

FIGURE 41. EUROPE COMPUTATIONAL BIOLOGY MARKET SHARE (%), BY END-USER, 2021&ndash;2029 ($MILLION)

FIGURE 42. EUROPE COMPUTATIONAL BIOLOGY MARKET SHARE (%), BY COUNTRIES, 2021&ndash;2029 ($MILLION)

FIGURE 43. ASIA PACIFIC COMPUTATIONAL BIOLOGY MARKET VALUE, 2021&ndash;2029 ($MILLION)

FIGURE 44. ASIA PACIFIC COMPUTATIONAL BIOLOGY MARKET SHARE (%), BY APPLICATION, 2021&ndash;2029 ($MILLION)

FIGURE 45. ASIA PACIFIC COMPUTATIONAL BIOLOGY MARKET SHARE (%), BY TOOL, 2021&ndash;2029 ($MILLION)

FIGURE 46. ASIA PACIFIC COMPUTATIONAL BIOLOGY MARKET SHARE (%), BY SERVICE, 2021&ndash;2029 ($MILLION)

FIGURE 47. ASIA PACIFIC COMPUTATIONAL BIOLOGY MARKET SHARE (%), BY END-USER, 2021&ndash;2029 ($MILLION)

FIGURE 48. ASIA PACIFIC COMPUTATIONAL BIOLOGY MARKET SHARE (%), BY COUNTRIES, 2021&ndash;2029 ($MILLION)

FIGURE 49. MIDDLE EAST AND AFRICA COMPUTATIONAL BIOLOGY MARKET VALUE, 2021&ndash;2029 ($MILLION)

FIGURE 50. MIDDLE EAST AND AFRICA COMPUTATIONAL BIOLOGY MARKET SHARE (%), BY APPLICATION, 2021&ndash;2029 ($MILLION)

FIGURE 51. MIDDLE EAST AND AFRICA COMPUTATIONAL BIOLOGY MARKET SHARE (%), BY TOOL, 2021&ndash;2029 ($MILLION)

FIGURE 52. MIDDLE EAST AND AFRICA COMPUTATIONAL BIOLOGY MARKET SHARE (%), BY SERVICE, 2021&ndash;2029 ($MILLION)

FIGURE 53. MIDDLE EAST AND AFRICA COMPUTATIONAL BIOLOGY MARKET SHARE (%), BY END-USER, 2021&ndash;2029 ($MILLION)

FIGURE 54.&nbsp;&nbsp; &nbsp;CHEMICAL COMPUTING GROUP.: FINANCIALS

FIGURE 55.&nbsp;&nbsp; &nbsp;SIMULATION PLUS INC: FINANCIALS

FIGURE 56.&nbsp;&nbsp; &nbsp;GENEDATA AG: FINANCIALS

FIGURE 57.&nbsp; &nbsp;&nbsp;NIMBUS DISCOVERY LLC.: FINANCIALS

FIGURE 58.&nbsp;&nbsp; &nbsp;RHENOVIA PHARMA SAS.: FINANCIALS

FIGURE 59.&nbsp;&nbsp; &nbsp;COMPUGEN LTD.: FINANCIALS

FIGURE 60.&nbsp;&nbsp; &nbsp;&nbsp;CERTARA.: FINANCIALS

FIGURE 61.&nbsp;&nbsp; &nbsp;ACCELRYS: FINANCIALS

FIGURE 62&nbsp;&nbsp; &nbsp;INSILICO BIOTECHNOLOGY AG: FINANCIALS

FIGURE 63.&nbsp;&nbsp; &nbsp;STRAND LIFE SCIENCES PVT LTD: FINANCIALS

&nbsp;